Europe Automated Insulin Delivery Systems Market was valued at USD 1.4 Billion in 2022 and is projected to reach USD 3.5 Billion by 2030, growing at a CAGR of 12.0% from 2024 to 2030.
The Europe Automated Insulin Delivery Systems Market is experiencing rapid growth, driven by advancements in diabetes management technology. Automated insulin delivery (AID) systems have emerged as a breakthrough for individuals with Type 1 and Type 2 diabetes, offering more precise, reliable, and personalized insulin administration. These systems typically combine an insulin pump with continuous glucose monitoring (CGM) technology, enabling the automatic adjustment of insulin delivery based on real-time glucose readings.
The demand for automated insulin delivery systems in Europe is being shaped by several factors. First, the increasing prevalence of diabetes across the region is a major driving force. According to recent data, over 60 million people in Europe suffer from diabetes, with a significant portion relying on insulin therapy. With the aging population and growing awareness about the benefits of AID systems, the market is poised for further expansion. Additionally, advancements in technology, such as improved algorithms and sensor technologies, have enhanced the accuracy and functionality of these devices, making them more attractive to both patients and healthcare providers.
Industries across Europe are particularly focused on the customization and integration of AID systems to meet the varying needs of patients. This includes the development of systems that are compatible with different types of insulin pumps and sensors, ensuring that patients can select the most suitable option for their condition. Another key requirement from industries is the focus on data security, as AID systems transmit sensitive health information. Ensuring compliance with privacy regulations, such as the GDPR, is a priority for manufacturers and healthcare providers alike.
Moreover, the regulatory environment in Europe is evolving to accommodate these technological advancements. The European Medicines Agency (EMA) and other national health authorities are working closely with device manufacturers to establish clear guidelines for the approval and monitoring of AID systems. This regulatory support is crucial in boosting market confidence and ensuring that products meet the highest safety and quality standards.
As the market grows, the focus on accessibility is also increasing. Manufacturers are working to develop cost-effective solutions to make these systems more affordable and accessible to a wider range of patients. The push for lower-cost, higher-performance automated insulin delivery systems aligns with the growing demand for affordable healthcare solutions across Europe.
With advancements in automated insulin delivery technology, the European market is becoming a critical hub for innovation and patient-centered care. As the industry continues to evolve, the focus on personalization, regulatory support, and cost-effective solutions will shape the future of diabetes management in the region.
Get an In-Depth Research Analysis of the Europe Automated Insulin Delivery Systems Market Size And Forecast [2025-2032]
Eli Lily
Tandem
Insulet
Big Foot Biomedical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Automated Insulin Delivery Systems Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Automated Insulin Delivery Systems Market
Insulin Pumps
Continuous Glucose Monitors (CGMs)
Hybrid Closed-Loop Systems
Automated Insulin Delivery Software
Wearable Devices
Sensor-augmented Pump Systems
Threshold-Suspend Systems
Full Closed-Loop Systems
Bluetooth-enabled Devices
Artificial Pancreas Devices
Hospitals and Clinics
Homecare Settings
Diabetes Specialty Clinics
Research and Academic Institutions
Long-term Care Facilities
External Insulin Delivery Systems
Implantable Insulin Delivery Systems
Disposable Systems
Reusables
Smart Insulin Pens
Type 1 Diabetes Management
Type 2 Diabetes Management
Gestational Diabetes Management
Pediatric Diabetes Care
Emergency Hypoglycemia Management
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Automated Insulin Delivery Systems Market Research Analysis
1. Introduction of the Europe Automated Insulin Delivery Systems Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Automated Insulin Delivery Systems Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Automated Insulin Delivery Systems Market, By Type
6. Europe Automated Insulin Delivery Systems Market, By Application
7. Europe Automated Insulin Delivery Systems Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Automated Insulin Delivery Systems Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/